Transforming Concussion Care

Cohen Veterans Bioscience   Brain Trauma Foundation

Join Us For a Virtual Conversation

Transforming Concussion Care

Thursday, November 18, 2021, 4:30–5:30pm ET

Cohen Veterans Bioscience and the Brain Trauma Foundation are two nonprofits dedicated to advancing brain health. We are teaming up to set a new standard of care for our nation’s Veterans, active-duty service members, and millions of civilians worldwide who are affected by traumatic brain injury (TBI), including concussion. Together, we can find new ways to reduce patient symptoms, build tools for clinicians, and improve evidence-based guidelines.

Time is of the essence. Innovative team-based approaches and research are needed to tackle these “invisible wounds” and provide hope for all those affected by TBI.

Register to Attend:
  • This field is for validation purposes and should be left unchanged.

 

 

Featured Speakers:

Frank LarkinFrank Larkin, 40th U.S., Senate Sergeant at Arms (Ret.),
U.S. Navy SEAL (Ret.)

Chair, Cohen Veterans Bioscience Veterans Advisory Council

Frank Larkin served as a Navy SEAL from 1975 to 1981. He then worked as a police officer, homicide detective, and peace officer–flight paramedic. In 1984 he joined the United States Secret Service as a special agent. He served in the Presidential Protection Division and retired from the Secret Service in 2006. From 2015 to 2018, he served as the 40th Sergeant at Arms of the United States Senate. Having experienced the impact of military trauma both professionally and personally, Mr. Larkin is committed to improving Veterans’ healthcare.

 

Magali Haas, MD, PhDMagali Haas, MD, PhD
CEO & President, Cohen Veterans Bioscience

Dr. Haas is founder of Cohen Veterans Bioscience (CVB), a global organization that leads pioneering efforts in PTSD and TBI research, including clinical trials, biotechnology, genetics, and biomarker discovery. She has more than 15 years of pharmaceutical leadership experience in neuroscience clinical development, translational medicine, and diagnostics, primarily at J&J. Dr. Haas has spearheaded the Brain Trauma Blueprint initiative to establish a national roadmap for PTSD & TBI precision therapeutics research.

 

Jamshid Ghajar, MD, PhD, FACSJamshid Ghajar, MD, PhD, FACS
President Emeritus, Brain Trauma Foundation

Dr. Ghajar is a board-certified neurosurgeon. In 2014, he joined the neurosurgery faculty at Stanford, where he is a clinical professor of neurosurgery and the Moghadam Family Director of the Stanford Brain Performance Center, Stanford University School of Medicine. He founded the Brain Trauma Foundation to develop and implement best practice guidelines for TBI, with the goal of improving patients’ lives.

 

We invite you to learn more about the Brain Trauma Blueprint, which identifies research priorities and fosters collaboration across the research, healthcare, and policy communities to advance precision diagnostics and tailored therapeutics for survivors of brain trauma. Our shared mission is to improve the lives of all individuals with TBI.